Verastem – VSTM – Acquires Clinical-Stage FAK Inhibitor from Pfizer
Verastem, Inc., (NASDAQ: VSTM) a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced an agreement with Pfizer for the exclusive in-license of...